Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. TARGRETIN (bexarotène)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TARGRETIN (bexarotène)

Medicine - Posted on Mar 28 2012 - Updated on Jun 12 2019
Active substance (DCI)
  • bexarotène
history (3)
  • 3/28/12

    TARGRETIN (bexarotène)

    Pas d’avantage clinique démontré dans la prise en charge du lymphome cutané T épidermotrope au stade avancé et réfractaire à...
    CAV :
    54321
    icône flèche
  • 7/4/07

    TARGRETIN (bexarotène)

    TARGRETIN (bexarotène)
    CAV :
    54321
    icône flèche
  • 4/3/02

    TARGRETIN 75mg, capsules molles, Flacon de 100 capsules (bexarotène)

    TARGRETIN 75mg, capsules molles, Flacon de 100 capsules (bexarotène)
    icône flèche
Technical information
ATC code
  • L01XX25
Manufacturer
Laboratoire CEPHALON FRANCE
Presentation

TARGRETIN 75 mg, capsule molle B/1 flacon polyéthylène haute densité (PEHD) de 100 capsules - Code CIP : 3657479

All our publications
    Drug therapy Skin and connective tissue cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
FVMbH51S0uJjZraV